Home
NRG Pallas

NRG Pallas Market Share Analysis for August 2026

Industry: N/A

Domainnrgpallas.com

Year Founded1998

Employees201 - 500

Annual Revenue--

NRG Pallas

NRG Pallas (including company regionals)

nrgpallas.com

See more website traffic and engagement information

Total visits to NRG Pallas's top domains

Understand NRG Pallas market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nrgpallas.com10.3K

See more with Sales Intelligence

Avg. visit duration in NRG Pallas's top domains

Analyze NRG Pallas engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nrgpallas.com00:00:21

See more with Sales Intelligence

Avg. pageviews on NRG Pallas's top domains

See how NRG Pallas keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nrgpallas.com1.75

See more with Sales Intelligence

NRG Pallas top competitors by domain

Top similar sites in August 2026, ranked by their affinity

curiumpharma.comCompany NameCurium PharmaEmployees1001 - 5000HQFrance, parísAnnual revenue$500M - $1BTotal visits16.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by NRG Pallas

These are the website technologies, by industry, used by NRG Pallas top domains

Mobile (3)

Meta Viewport

Social (3)

Instagram

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

More Technologies

7

See all

News & Signals from NRG Pallas

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJoost will leave Nrg Pallas as Executive Director Nuclear Energy Services on Nov 1st '26.Joost will succeed Ad Louter on 1 November 2026 and joins Urenco from NRG PALLAS, where his most recent position was Executive Director Nuclear Energy Services on the Executive Committee.

NewsFramatome signs new client Pallasreactor.NRG PALLAS has selected Framatome to deliver the first reactor protection system (FRPS) for the PALLAS new reactor for the production of medical isotopes and nuclear research, currently under construction in Petten, Netherlands.

NewsPallasreactor is developing access to lead-212 for cancer drug development across Europe.TAG1 and NRG Pallas have signed a letter of intent to jointly develop access to lead-212 (Pb-212) for cancer drug development across Europe.